Stay updated on Upadacitinib Efficacy in Atopic Dermatitis Clinical Trial

Sign up to get notified when there's something new on the Upadacitinib Efficacy in Atopic Dermatitis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Upadacitinib Efficacy in Atopic Dermatitis Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    A new 2026 publication citation regarding achieving minimal disease activity in atopic dermatitis and real-world MEASURE-AD data has been added, including authors, title, journal, date, and DOI (online ahead of print).
    Difference
    0.0%
    Check dated 2026-08-05T00:51:37.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    The release notes now display revision v3.6.4, replacing the previous v3.6.3 tag.
    Difference
    0.0%
    Check dated 2026-07-21T23:00:45.000Z thumbnail image
  4. Check
    28 days ago
    No Change Detected
  5. Check
    42 days ago
    Change Detected
    Summary
    Added a new publication citation for Eyerich et al. on Upadacitinib in atopic dermatitis (head and neck region) with full bibliographic details. The page revision has been updated to v3.6.3 to reflect this publication change and replaces the previous v3.6.0.
    Difference
    0.0%
    Check dated 2026-06-30T02:54:04.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    The page now displays a recruitment status notice 'No longer looking for participants' and introduces new help/navigation sections such as 'How to Read a Study Record', 'Common Questions', and 'How to Join a Study'. In addition, the header text changed from 'Intervention / Treatment' to 'Intervention/Treatment' and the site revision tag updated to 'Revision: v3.6.0'.
    Difference
    0.1%
    Check dated 2026-06-15T23:25:52.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    Two new trial sites were added (Thessaloniki, Greece and Bucheon-si, South Korea) and two existing sites were removed, updating the list of study locations. The study plan section was updated to include the double-blind dosing with Week 16 re-randomization and AbbVie’s data-sharing commitments with related links.
    Difference
    0.5%
    Check dated 2026-06-09T01:35:25.000Z thumbnail image
  8. Check
    70 days ago
    Change Detected
    Summary
    A new publication entry has been added to the Publications section of the study record. It cites Eyerich et al.'s work on Upadacitinib efficacy in atopic dermatitis of the head and neck region (Dermatol Ther Heidelb, 2026; online ahead of print).
    Difference
    0.0%
    Check dated 2026-06-02T01:05:32.000Z thumbnail image

Stay in the know with updates to Upadacitinib Efficacy in Atopic Dermatitis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Upadacitinib Efficacy in Atopic Dermatitis Clinical Trial page.